Interwell Health Welcomes Esteemed Nephrologist to Board of Directors
On February 4, 2025, Interwell Health, a company that specializes in value-based care for kidney patients, announced the appointment of Dr. Michael J. Casey, an esteemed nephrologist and the president of North Carolina Nephrology, P.A., as the newest member of its Board of Directors. This significant addition aims to fortify the leadership team and enhance the company’s commitment to delivering exceptional kidney care. Dr. Casey joins Dr. Charles Zachem on the board, nominated by physician investors associated with Interwell.
With over 20 years of experience in nephrology, Dr. Casey is recognized as a pioneer in adopting value-based care models tailored for kidney disease treatment. His extensive background is complemented by his involvement in research, acting as a principal investigator in multiple clinical trials aimed at enhancing treatments for chronic kidney disease (CKD) and hypertension. His role comes as a successor to Dr. Carney Taylor, who has transitioned to a full-time role within Interwell's medical office.
"Nephrologists are central to our care model, and their leadership is vital for supporting our provider network with a deep understanding of on-the-ground challenges," stated Robert Sepucha, CEO of Interwell. He also highlighted Dr. Casey's contributions as a leading physician partner, emphasizing the impact of his practice in pioneering value-based care for patients. With Dr. Casey's appointment, the board anticipates a continued commitment to improving clinical outcomes and reducing the financial burden associated with kidney care for both patients and healthcare payers.
Dr. Carney Taylor’s new full-time role adds to the expertise within Interwell's medical office. He will collaborate alongside prominent physician leaders, including Dr. George Hart, Dr. Julie Dominguez, and Dr. Terry Ketchersid. Previously, Dr. Taylor co-presided over Eastern Nephrology Associates in North Carolina, where he was instrumental in achieving some of the highest quality scores in national government value-based programs. "We are excited to have Carney join the leadership team at Interwell," expressed Dr. Hart, the chief medical officer. He reiterated the importance of frontline experience in expanding value-based models and enhancing patient lives.
In 2024, Interwell Health reported extraordinary results in the government’s value-based kidney care model, achieving top rankings in quality scores while also realizing significant total savings. This success underscores the effectiveness of Interwell’s comprehensive approach, which emphasizes personalized care management through its Interwell 360 platform, a nephrology-specific Electronic Health Record system known as Acumen® Epic Connect, and advanced predictive analytics.
Interwell Health is dedicated to redefining kidney care, striving to provide patients with the quality of life they deserve. The organization's innovative model combines patient-centric care with provider empowerment, addressing the needs of chronic kidney disease patients from stage 3 all the way to kidney failure. With partnerships forged with over 2,000 nephrologists, Interwell utilizes advanced machine learning algorithms to tailor care for patients across all 50 states and Puerto Rico.
For more details about Interwell Health and its transformative approach to kidney care, you can visit their official website at interwellhealth.com. The commitment to excellence in value-based services continues to position Interwell as a trailblazer in the healthcare industry, setting a new benchmark in specialty care for kidney patients.
With over 20 years of experience in nephrology, Dr. Casey is recognized as a pioneer in adopting value-based care models tailored for kidney disease treatment. His extensive background is complemented by his involvement in research, acting as a principal investigator in multiple clinical trials aimed at enhancing treatments for chronic kidney disease (CKD) and hypertension. His role comes as a successor to Dr. Carney Taylor, who has transitioned to a full-time role within Interwell's medical office.
"Nephrologists are central to our care model, and their leadership is vital for supporting our provider network with a deep understanding of on-the-ground challenges," stated Robert Sepucha, CEO of Interwell. He also highlighted Dr. Casey's contributions as a leading physician partner, emphasizing the impact of his practice in pioneering value-based care for patients. With Dr. Casey's appointment, the board anticipates a continued commitment to improving clinical outcomes and reducing the financial burden associated with kidney care for both patients and healthcare payers.
Dr. Carney Taylor’s new full-time role adds to the expertise within Interwell's medical office. He will collaborate alongside prominent physician leaders, including Dr. George Hart, Dr. Julie Dominguez, and Dr. Terry Ketchersid. Previously, Dr. Taylor co-presided over Eastern Nephrology Associates in North Carolina, where he was instrumental in achieving some of the highest quality scores in national government value-based programs. "We are excited to have Carney join the leadership team at Interwell," expressed Dr. Hart, the chief medical officer. He reiterated the importance of frontline experience in expanding value-based models and enhancing patient lives.
In 2024, Interwell Health reported extraordinary results in the government’s value-based kidney care model, achieving top rankings in quality scores while also realizing significant total savings. This success underscores the effectiveness of Interwell’s comprehensive approach, which emphasizes personalized care management through its Interwell 360 platform, a nephrology-specific Electronic Health Record system known as Acumen® Epic Connect, and advanced predictive analytics.
Interwell Health is dedicated to redefining kidney care, striving to provide patients with the quality of life they deserve. The organization's innovative model combines patient-centric care with provider empowerment, addressing the needs of chronic kidney disease patients from stage 3 all the way to kidney failure. With partnerships forged with over 2,000 nephrologists, Interwell utilizes advanced machine learning algorithms to tailor care for patients across all 50 states and Puerto Rico.
For more details about Interwell Health and its transformative approach to kidney care, you can visit their official website at interwellhealth.com. The commitment to excellence in value-based services continues to position Interwell as a trailblazer in the healthcare industry, setting a new benchmark in specialty care for kidney patients.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.